Bristol-Myers Squibb and Johnson & Johnson are both companies that are currently targets of LB Pharmaceuticals.

The entities involved

• Bristol-Myers Squibb →

  American pharmaceutical company

  • Major pharmaceutical companies licensed drug delivery technologies like Enhanze and Hypercon for various applications.16:54
  • Gardiner Harris's investigative reporting led to fraud fines against Bristol-Myers Squibb and a book dissecting Johnson & Johnson scandals.Tue 01:35
• Johnson & Johnson →

  U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

  • Johnson & Johnson acquired Intra-Cellular Therapies and is seeking FDA approval for related drugs.16:46
  • Zusduri, a product of Urogen Pharma, is gaining market traction against competitors like MSD's Keytruda and Ferring's Adstiladrin.04:48

Related events

• AstraZeneca sought a mega-merger with a US rival, adding a specific development to the ongoing talks with Bristol-Myers Squibb.Aug 9
• AbbVie, Johnson & Johnson, Bristol-Myers Squibb, and Amgen are innovating targeted, cost-effective therapies for psoriatic arthritis.Jun 8
• Johnson & Johnson was referenced in a recent news report concerning New York City.Oct 21
• Bristol-Myers Squibb and AbbVie secured regulatory approval for a therapy in the US.Oct 21